alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.3**CERTIFICATIONS**I, Randy Underwood, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Dollar Financial Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officers and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and  h) Disclosed in this report any change in the registrant’s internal controlover financial reporting that occurred during the registrant’s most recent fiscalquarter (the registrant’s fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and 5. The registrant’s other certifying officers and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions): a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likelyto adversely affect the registrant’s ability to record, process, summarize andreport financial information; and  b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.Date:February 13, 2006       */s/ Randy Underwood*         Randy Underwood    Executive Vice President andChief Financial Officer  
44
Efrain J. ROSA, Petitioner, v. R.L. RHODES, Warden.

No. 19-6909.

Supreme Court of the United States.

April 27, 2020

Petition for rehearing denied.
Robert W. JOHNSON, Petitioner, v. Andrew M. SAUL, Commissioner of Social Security.

No. 19-6559

Supreme Court of the United States.

Jan. 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
Dijon Rasheed BROWN, Petitioner v. UNITED STATES

No. 19-6603

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Exhibit 32.1











CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report on Form 10-Q of Energy Holdings International, Inc. (the “Company”) for the quarter ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Adair, Chairman, President and Chief Executive Officer and Chief Financial Officer  of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:





(i)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date: November 12, 2010

/s/    John AdairJohn AdairChairman, President and

Chief Executive Officer





This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
Michigan Supreme Court Lansing, Michigan

Robert P. Young, Jr.,
Chief Justice

Michael F. Cavanag h Marilyn Kell y Stephen J. Markma n Diane M. Hathawa y Mary Beth Kell y Brian K. Zahra,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk July 29, 2011

t0726 

# Order

July 29, 2011

141838

TARIEN A. HATCHER and MARKQUITA FREDERICK, Co-Persona l Representatives of the Estate of Kimora N. Hatcher, Deceased, Plaintiffs-Appellants, and

TARIEN A. HATCHER, Individually, MARKQUITA FREDERICK, Individually, TARIEN A. HATCHER, as Next Friend of Latariea Hatcher, a Mi nor, YVETTE HATCHER, ISABEL L. KUHLMAN, and JOSEPH EARLE, Plaintiffs,

v SC: 141838 COA: 289208 Macomb CC: 2 007-001452-NO SENIOR HOME HEALTH CARE, INC., Defendant-Appellee.

________________ _______________ __________/

On order of the Court, the applicati on for leave to appeal the August 19, 2010 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the question pres ented should be reviewed by this Court. The plaintiffs
have failed to show that the defendant had a legal duty to th em separate and distinct from its contractual obligations. Fultz v Union Commerce Assoc, 470 Mich 460, 467 (2004). Although a contracting party’s assumption of contractual obligations does not extinguish or limit separately existing common-law or st atutory tort duties owed to noncontracting third parties in the perfo rmance of a contract, Loweke v Ann Arbo r Ceiling & Partition Co, LLC , 489 Mich ___ (Docket No. 141168, decided June 6, 20 11), the plaintiffs have
not shown that the defendant ha d any such separate duty to them. The defendant, as the provider of a nondefective product to a cust omer, did not thereby acquire a duty to all unknown third parties who might be injured by the customer’s misuse of the product.

C AVANAGH , M ARILYN K ELLY and H ATHAWAY , JJ., would vacate the judgment of the Court of Appeals and remand this case to the Macomb Circu it Court for further proceedings consistent with this Court’s opinion in Loweke v Ann Arbor Ceiling & Partition Co, LLC , 489 Mich ___ (Docke t No. 141168, decided June 6, 2011).
10F-3 REPORT

                 HIGH INCOME OPPORTUNITY FUND INC.

        October 1, 2001 through September 30, 2002

                            Trade                                        % of
Issuer                       Date     Selling Dealer  Amount   Price Issue(1)

Standard Pacific Corp.    4/10/02   CS First Boston   $875,000 $99.200 3.33%A
9.250% due 4/15/12

Vintage Petroleum         4/25/02   DB Alex Brown    1,210,000 100.000 2.00B
8.250% due 5/1/12

Johnsondiversey Inc.      4/29/02   Goldman Sachs      520,000 100.000 1.00C
9.625% due 5/15/12

Avaya Inc.                3/22/02   CS First Boston  1,400,000  98.812 1.82D
10.000% due 5/15/09

Lyondell Chemical Co.    11/30/01   J.P. Morgan Chase  315,000  99.248 3.60E
9.500% due 12/15/08

Generale de Geophysique    2/5/02   RBC Dominnion Sec. 520,000 100.00  6.00F
10.625% due 11/15/07

Dana Corp.                 3/6/02  Bankof America Sec. 875,000  98.659 2.00G
10.125% due 3/15/10

Foamex L.P.               3/20/02   CS First Boston    870,000 100.00  1.67H
10.750% due 4/1/09

Rite Aid Corp.           11/14/01   J.P. Morgan Chase   90,000 100.00  0.46I
4.750% due 12/1/06

Allied Waste North America 11/15/01 J.P Morgan Chase 2,580,000 100.00  2.00J
8.500% due 12/1/08

GAP Inc.                 11/16/01   Goldman Sachs    1,720,000  99.769 2.00K
8.800% due 12/15/08

Revlon Consumer Products 11/19/01   Bear Stearns     2,950,000  96.569 4.68L
12.000% due 12/1/05


(1) Represents purchases by all affiliated funds; may not exceed
    25% of the principal amount of the offering.

A - Includes purchases of $4,125,000 by other Smith Barney Mutual Funds.
B - Includes purchases of $5,790,000 by other Smith Barney Mutual Funds.
C - Includes purchases of $2,480,000 by other Smith Barney Mutual Funds.
D - Includes purchases of $6,600,000 by other Smith Barney Mutual Funds.
E - Includes purchases of $6,700,000 by other Smith Barney Mutual Funds.
F - Includes purchases of $2,480,000 by other Smith Barney Mutual Funds.
G - Includes purchases of $4,125,000 by other Smith Barney Mutual Funds.
H - Includes purchases of $4,130,000 by other Smith Barney Mutual Funds.
I - Includes purchases of $820,000 by other Smith Barney Mutual Funds.
J - Includes purchases of $12,420,000 by other Smith Barney Mutual Funds.
K - Includes purchases of $8,280,000,000 by other Smith Barney Mutual Funds.
L - Includes purchases of $14,050,000 by other Smith Barney Mutual Funds.
Leroy BACA, Petitioner, v. UNITED STATES.

No. 19-102

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
HENRY SCHEIN, INC., Applicant, v. ARCHER AND WHITE SALES, INC.

No. 19A766

Supreme Court of the United States.

January 24, 2020

Application for stay presented to Justice Alito and by him referred to the Court granted, and the proceedings in the United States District Court for the Eastern District of Texas, case No. 2:12- cv-572, is stayed pending the timely filing and disposition of a petition for writ of certiorari. Should the petition for writ of certiorari be denied, this stay shall terminate automatically. In the event the petition for writ of certiorari is granted, the stay shall terminate upon the sending down of the judgment of this Court.

Justice Ginsburg would deny the application.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Career Development (Ks) and Conference Support (R13) Review.                    

*Date:*                         July 19, 2022.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Ruixia Zhou, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, (301) 496-4773,                         *zhour@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, HHS)

Dated: June 15, 2022.

Victoria E. Townsend,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-13238 Filed 6-17-22; 8:45 am]

BILLING CODE 4140-01-P
John HUDSON, Petitioner v. UNITED STATES

No. 19-6209

Supreme Court of the United States.

November 12, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
# CE2004065EN.01027401.xml

| 13.3.2004 | EN | Official Journal of the European Union | CE 65/274 |
| --------- | -- | -------------------------------------- | --------- |

---

(2004/C 65 E/289)

WRITTEN QUESTION E-3504/03

by Hiltrud Breyer (Verts/ALE) to the Commission

(24 November 2003)

Subject:   Information on the level of EU funding granted to Rhineland-Palatinate between January 1997 and December 2002

| 1. | For what measures was EU funding paid to Rhineland-Palatinate between 1997 and 2002, and what were the sums involved from the following programmes and funds:
(a)
the European Social Fund; (b)
the Fifth Framework Programme for Research; (c)
the European Regional Development Fund; (d)
EU environmental and energy programmes; (e)
the European Agricultural Guidance and Guarantee Fund (Guidance Section and Guarantee Section); (f)
other EU programmes? | (a) | the European Social Fund; | (b) | the Fifth Framework Programme for Research; | (c) | the European Regional Development Fund; | (d) | EU environmental and energy programmes; | (e) | the European Agricultural Guidance and Guarantee Fund (Guidance Section and Guarantee Section); | (f) | other EU programmes? |
| --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --- | ------------------------- | --- | ------------------------------------------- | --- | --------------------------------------- | --- | --------------------------------------- | --- | ----------------------------------------------------------------------------------------------- | --- | -------------------- |
| (a) | the European Social Fund; | | | | | | | | | | | | |
| (b) | the Fifth Framework Programme for Research; | | | | | | | | | | | | |
| (c) | the European Regional Development Fund; | | | | | | | | | | | | |
| (d) | EU environmental and energy programmes; | | | | | | | | | | | | |
| (e) | the European Agricultural Guidance and Guarantee Fund (Guidance Section and Guarantee Section); | | | | | | | | | | | | |
| (f) | other EU programmes? | | | | | | | | | | | | |

| 2. | How much was paid from the programmes and funds for cross-border projects involving Rhineland-Palatinate and, respectively, Luxembourg, Belgium, Lorraine and Alsace? What are the projects involved in each case? |
| -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |

Answer given by Mr Prodi on behalf of the Commission

(2 December 2003)

The Commission is collecting the information it needs to answer the question. It will communicate its findings as soon as possible.

---
Tyrone Marvin ANDREWS, Petitioner, v. Noah NAGY, Warden.

No. 19-6727

Supreme Court of the United States.

January 27, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002



In connection with the Amendment No. 1 to
Annual Report of VectoIQ Acquisition Corp. (“the Company”) on Form 10-K/A for the year ended December 31, 2019, as
filed with the Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), I, Stephen
Girsky, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------
| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: April 15, 2020



| | /s/ Stephen Girsky     
| | -----------------------
| | Stephen Girsky         
| | Chief Executive Officer
# Official Journal L 2/2015

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 2 |
| | |
| English edition | Legislation | Volume 586 January 2015 |

ISSN 1977-0677

Official Journal

of the European Union

L 2

English edition

Legislation

Volume 586 January 2015

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Delegated Regulation (EU) 2015/1 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards for the periodic reporting on fees charged by credit rating agencies for the purpose of ongoing supervision by the European Securities and Markets Authority (
  1
  ) | 1 |
| | * | Commission Delegated Regulation (EU) 2015/2 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards for the presentation of the information that credit rating agencies make available to the European Securities and Markets Authority (
  1
  ) | 24 |
| | * | Commission Delegated Regulation (EU) 2015/3 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards on disclosure requirements for structured finance instruments  (
  1
  ) | 57 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Delegated Regulation (EU) 2015/1 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards for the periodic reporting on fees charged by credit rating agencies for the purpose of ongoing supervision by the European Securities and Markets Authority (
  1
  )

1

1

*

Commission Delegated Regulation (EU) 2015/2 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards for the presentation of the information that credit rating agencies make available to the European Securities and Markets Authority (
  1
  )

1

24

*

Commission Delegated Regulation (EU) 2015/3 of 30 September 2014 supplementing Regulation (EC) No 1060/2009 of the European Parliament and of the Council with regard to regulatory technical standards on disclosure requirements for structured finance instruments  (
  1
  )

1

57

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Lorie Anne Gunderson ZARUM, as Personal Representative of the Estate of Theodore Lee Gunderson, Petitioner v. HOAG MEMORIAL HOSPITAL PRESBYTERIAN, et al.

No. 19-6724

Supreme Court of the United States.

January 27, 2020

Petition for writ of certiorari to the Court of Appeal of California, Second Appellate District denied.